Trials / Recruiting
RecruitingNCT06039917
Effect of the Automatic Surveillance System on Surveillance Rate of Patients with Gastric Premalignant Lesions
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,460 (estimated)
- Sponsor
- Renmin Hospital of Wuhan University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this study, we proposed a prospective study about the effect of the automatic surveillance system on surveillance rate of patients with gastric premalignant lesions. The enrolled patients were divided into group A with intelligent surveillance system, group B with manual reminder, and group C with natural state. The surveillance among the three groups will be compared.
Detailed description
The adherence of doctors to published surveillance guidelines for patients with gastric premalignant lesions varies greatly, and surveillance of patients is critical but time-consuming. In previous studies we developed an automatic surveillance (AS) system to accurately identify patients with gastric premalignant lesions, assign surveillance intervals for different risks of patients and proactively follow up with patients in time. In this study, we proposed a prospective study about the effect of the automatic surveillance system on surveillance rate of patients with gastric premalignant lesions. The enrolled patients were divided into group A with intelligent surveillance system, group B with manual reminder, and group C with natural state. The surveillance among the three groups will be compared.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | AI based automatic surveillance (AS) system (ENDOANGEL-AS) | An automatic surveillance (AS) system accurately identify patients with gastric premalignant lesions, assign surveillance intervals for different risks of patients and proactively follow up with patients at certain times. |
| OTHER | Manually remind the patients | Medical staff remind patients to review manually. |
Timeline
- Start date
- 2023-09-10
- Primary completion
- 2028-12-31
- Completion
- 2029-12-31
- First posted
- 2023-09-15
- Last updated
- 2024-11-04
Locations
4 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06039917. Inclusion in this directory is not an endorsement.